E.g., 07/21/2019
E.g., 07/21/2019
Title Category Credit Event date Price
Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Webcast (2018)
  • 7.75 AMA PRA Category 1 Credit™
  • 7.75 Non-Physician Participation
$0.00 Urologists continue to indicate one of the greatest educational needs in integrating systemic agents into the management of advanced prostate cancer. With numerous new treatments now available to urologists to manage advanced disease, sequencing and managing the side effects of each treatment have become increasingly important.
Using Shared Decision Making to Help Patients Decide on Prostate Cancer Screening and Treatment Webcast 037IC (2019)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$0.00 Shared Decision Making was recently accepted as the standard of care when counseling patients considering PSA screening by the US Preventative Services Taskforce. Shared Decision Making is also embedded into numerous recently published AUA guidelines (including the localized prostate cancer guideline). In spite of these clear recommendations, Shared Decision Making is not frequently used in clinical practice. 
Writing A Successful Career Development Award Application (2018) $149.00 This educational activity is made possible with support from the Yemini Family Foundation and the Urology Care Foundation.